Wordt geladen...
Melanoma: A model for testing new agents in combination therapies
Treatment for both early and advanced melanoma has changed little since the introduction of interferon and IL-2 in the early 1990s. Recent data from trials testing targeted agents or immune modulators suggest the promise of new strategies to treat patients with advanced melanoma. These include a new...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2873374/ https://ncbi.nlm.nih.gov/pubmed/20406483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-8-38 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|